DRUG
Price
$30.70
Change
-$0.19 (-0.62%)
Updated
Apr 30 closing price
Capitalization
221.67M
RANI
Price
$1.11
Change
-$0.00 (-0.00%)
Updated
Apr 30 closing price
Capitalization
37.26M
6 days until earnings call
Ad is loading...

DRUG vs RANI

Header iconDRUG vs RANI Comparison
Open Charts DRUG vs RANIBanner chart's image
Bright Minds Biosciences
Price$30.70
Change-$0.19 (-0.62%)
Volume$39.14K
Capitalization221.67M
Rani Therapeutics Holdings
Price$1.11
Change-$0.00 (-0.00%)
Volume$90.74K
Capitalization37.26M
DRUG vs RANI Comparison Chart
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. RANI commentary
May 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a StrongBuy and RANI is a Hold.

Ad is loading...
COMPARISON
Comparison
May 01, 2025
Stock price -- (DRUG: $30.51 vs. RANI: $1.11)
Brand notoriety: DRUG and RANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 108% vs. RANI: 50%
Market capitalization -- DRUG: $221.67M vs. RANI: $37.26M
DRUG [@Biotechnology] is valued at $221.67M. RANI’s [@Biotechnology] market capitalization is $37.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileRANI’s FA Score has 0 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • RANI’s FA Score: 0 green, 5 red.
According to our system of comparison, DRUG is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 6 TA indicator(s) are bullish while RANI’s TA Score has 5 bullish TA indicator(s).

  • DRUG’s TA Score: 6 bullish, 3 bearish.
  • RANI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DRUG is a better buy in the short-term than RANI.

Price Growth

DRUG (@Biotechnology) experienced а -10.53% price change this week, while RANI (@Biotechnology) price change was -3.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.45%. For the same industry, the average monthly price growth was +5.12%, and the average quarterly price growth was -6.68%.

Reported Earning Dates

DRUG is expected to report earnings on Aug 28, 2023.

RANI is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRUG($222M) has a higher market cap than RANI($37.3M). DRUG YTD gains are higher at: -15.297 vs. RANI (-18.978). DRUG has higher annual earnings (EBITDA): -2.67M vs. RANI (-48.72M). DRUG has more cash in the bank: 57.9M vs. RANI (30.4M). DRUG has less debt than RANI: DRUG (183K) vs RANI (33.7M). DRUG (0) and RANI (0) have equivalent revenues.
DRUGRANIDRUG / RANI
Capitalization222M37.3M595%
EBITDA-2.67M-48.72M5%
Gain YTD-15.297-18.97881%
P/E RatioN/AN/A-
Revenue00-
Total Cash57.9M30.4M190%
Total Debt183K33.7M1%
TECHNICAL ANALYSIS
Technical Analysis
DRUGRANI
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLCGX27.59N/A
N/A
Goldman Sachs Large Cap Gr Insghts A
TNVRX15.42N/A
N/A
1290 GAMCO Small/Mid Cap Value R
DEMZX20.91N/A
N/A
Macquarie Emerging Markets R6
FNIDX12.98N/A
N/A
Fidelity Intl Sustainability Idx
FSYKX9.04N/A
N/A
Fidelity Advisor Sustainable EM Eq C

DRUG and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRUG has been loosely correlated with PHMMF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DRUG jumps, then PHMMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRUG
1D Price
Change %
DRUG100%
-1.23%
PHMMF - DRUG
42%
Loosely correlated
N/A
IVA - DRUG
39%
Loosely correlated
-1.57%
PSTV - DRUG
33%
Poorly correlated
-8.22%
MNMD - DRUG
31%
Poorly correlated
+1.27%
ATYR - DRUG
31%
Poorly correlated
+2.66%
More

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with KYMR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
N/A
KYMR - RANI
34%
Loosely correlated
+1.66%
IMCR - RANI
33%
Loosely correlated
-1.21%
VYGR - RANI
33%
Loosely correlated
-0.70%
OCUL - RANI
32%
Poorly correlated
+1.10%
DRUG - RANI
31%
Poorly correlated
-1.23%
More